Who Owns Drugs Made In America Acquisition II Unit Stock?
NASDAQ: DMIIUFinancial ServicesShell CompaniesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 5.46%
- Held by insiders
- 1.07%
- Institutional holders
- 14
- Institutions 5.5%
- Insiders 1.1%
- Public and other 93.5%
Who owns Drugs Made In America Acquisition II Unit stock?
Institutional investors own about 5.5% of Drugs Made In America Acquisition II Unit's shares, spread across 14 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.07% of DMIIU.
The largest institutional holders are LMR Partners LLP (3.91%), Westchester Capital Management, LLC (0.98%) and BlueCrest Capital Management Ltd (0.49%). Together, the top 10 institutions control 6.7% of shares outstanding. In their latest filings, 0 of the top 10 institutions increased their DMIIU positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of DMIIU
| Institution | Shares | % Held | Change |
|---|---|---|---|
| LMR Partners LLP | 2.00M | 3.91% | 0.0% |
| Westchester Capital Management, LLC | 502.91K | 0.98% | 0.0% |
| BlueCrest Capital Management Ltd | 250.00K | 0.49% | 0.0% |
| Verition Fund Management, LLC | 250.00K | 0.49% | 0.0% |
| Walleye Capital LLC | 100.00K | 0.20% | 0.0% |
| L1 Global Manager Pty Ltd | 100.00K | 0.20% | 0.0% |
| Readystate Asset Management LP | 100.00K | 0.20% | 0.0% |
| HRT Financial LP | 99.72K | 0.19% | -0.3% |
| Rangeley Capital, LLC | 32.55K | 0.06% | -41.5% |
| Clear Street Group Inc. | 8.08K | 0.02% | -95.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of DMIIU
| Fund | Shares | % Held |
|---|---|---|
| Merger Fund-The Merger Fund | 414.52K | 0.81% |
| JNL Series Trust-JNL Multi-Manager Alternative Fund | 22.95K | 0.04% |
| Virtus Event Opportunities Trust-Virtus Westchester Event-Driven Fund | 22.21K | 0.04% |
| Virtus Event Opportunities Trust-Virtus Westchester Credit Event Fund | 16.05K | 0.03% |
| Principal Funds, Inc-Global Multi-Strategy Fund | 10.37K | 0.02% |
| JNL Series Trust-JNL/Westchester Capital Event Driven Fund | 8.07K | 0.02% |
| Merger Fund VL-The Merger Fund VL | 4.21K | 0.01% |
Frequently asked questions
Who is the largest shareholder of Drugs Made In America Acquisition II Unit?
LMR Partners LLP is the largest institutional shareholder of DMIIU, owning 3.91% of shares outstanding (2.00M shares) as of its latest 13F filing.
What percentage of Drugs Made In America Acquisition II Unit is owned by institutions?
Institutions own about 5.5% of DMIIU shares and 5.5% of the public float.
How much of Drugs Made In America Acquisition II Unit do insiders own?
Insiders, such as officers and directors, own about 1.07% of DMIIU shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.